Author:
Liu Qin,Chen Yuanyuan,Hu Yan,Yang Jiyuan
Reference103 articles.
1. New and emerging systemic therapeutic options for advanced cholangiocarcinoma;Massironi;Cells,2020
2. A practical guide for the systemic treatment of biliary tract cancer in Canada;Ramjeesingh;Curr. Oncol. (Toronto, Ont),2023
3. Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer;Rizzo;Expert Opin. Investig. Drugs,2021
4. The role and implication of autophagy in cholangiocarcinoma;Khizar;Cell Death Discov.,2023
5. Case report: preliminary response to tislelizumab plus S-1 in patients with metastatic gallbladder carcinoma: a report of five cases and a literature review;Zhang;Front. Immunol.,2023